Opioid Abuse, Naloxone Administration, and Guidance for U.S. Pharmacists in Drug Overdose
Emergencies

Activity Downloads

To Participate

To participate in this continuing education activity:

Review the activity description and objectives.

View the activity.

Complete the online post-test and activity evaluation.

SPECIAL ADVISORY NOTICE: This CE activity describes
a pharmacy protocol for dispensing naloxone via standing order which is legally acceptable
in some U.S. states. While many U.S. states have adopted similar protocols to the
one described in this CE activity, the authors of this activity strongly recommend
that all pharmacists refer to the published standards and protocols of their respective
State Boards of Pharmacy regarding naloxone dispensing, administration, and related
policies before making any changes to their practice. In addition, some State Boards
of Pharmacy require pharmacists to complete a certain number of hours of accredited
CE on the topic(s) of naloxone standing orders and/or opiate use and abuse prior to
making changes to their naloxone dispensing practices. Again, it is strongly recommended
that all pharmacists check the current published requirements and protocols of their
respective State Boards of Pharmacy before determining if this CE activity meets the
requirements for mandatory naloxone/opiate-related CE in their respective states.

Activity Description

This ACPE-accredited CE activity is designed to provide continuing education to
pharmacists who may dispense naloxone via a standing order or similar protocols allowed
by their respective states. In some states, a naloxone standing order allows eligible
pharmacists who have completed a certified training program in opioid overdose prevention
and/or who are CPR certified to both dispense naloxone and educate patients and potential
caregivers on how to properly administer naloxone.

Learning Objectives

The target audience for this activity is pharmacists. At the conclusion of this
activity, participants will be able to:

Faculty

Ruixuan Jiang, PharmD
Post-Doctoral Fellow
Department of Pharmacy Systems, Outcomes and Policy
University of Illinois at Chicago (UIC) College of Pharmacy

Todd Lee, PharmD, PhD
Professor
Department of Pharmacy Systems, Outcomes and Policy
University of Illinois at Chicago (UIC) College of Pharmacy

Simon Pickard, BScPharm, PhD
Professor
Department of Pharmacy Systems, Outcomes and Policy
University of Illinois at Chicago (UIC) College of Pharmacy

CE Accreditation

Release Date: 09-12-2016
Expiration Date: 09-12-2019

Pharmacists

This
CE activity is jointly provided by ProCE, Inc. and Second City Outcomes Research.
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a
provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-16-169-H04-P has
been assigned to this knowledge-based home-study CE activity (initial release date
09-12-16). This activity is approved for 1.5 contact hours (0.15 CEU) in states
that recognize ACPE providers. Completion of the evaluation and the post-test with
a score of 70% or higher are required to receive CE credit. No partial credit will
be given.

Funding

No external support has been received for this activity.

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and
scientific rigor in all of its continuing education activities. Faculty must disclose
to participants any significant financial interest or affiliation with companies that
manufacture or market products discussed in this activity. Todd Lee, Ruixuan
Jiang, and Simon Pickard have no relevant commercial and/or financial relationships
to disclose.

Please note: The information and views presented in this activity are those of
the faculty through clinical practice and knowledge of the professional literature.
Portions of this activity may include the use of drugs and/or devices for unlabeled
indications, which should be considered experimental. Participants are advised to
consult manufacturer product information and the professional literature, and use
professional judgment in applying the presented information in patient-care activities.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.